Ameren (AEE) Financials

$98.92 -0.09 (-0.09%)

Closing price 03:59 PM Eastern

Extended Trading

$99.04 +0.11 (+0.11%)

As of 04:28 PM Eastern

Annual Income Statements for Ameren

This table shows Ameren's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	630	653	523	815	828	871	990	1,074	1,152	1,182
Consolidated Net Income / (Loss)	636	659	529	821	834	877	995	1,079	1,157	1,187
Net Income / (Loss) Continuing Operations	585	659	529	821	834	877	995	1,079	1,157	1,187
Total Pre-Tax Income	948	1,041	1,105	1,058	1,016	1,032	1,152	1,255	1,340	1,270
Total Operating Income	1,259	1,322	1,410	1,357	1,267	1,300	1,333	1,515	1,558	1,516
Total Gross Profit	2,597	2,634	2,783	2,795	2,743	2,858	2,991	3,343	3,467	3,653
Total Revenue	6,098	6,076	6,174	6,291	5,910	5,794	6,394	7,957	7,500	7,623
Operating Revenue	6,098	6,076	6,174	6,291	5,910	5,794	6,394	7,957	7,500	7,623
Total Cost of Revenue	3,501	3,442	3,391	3,496	3,167	2,936	3,403	4,614	4,033	3,970
Operating Cost of Revenue	3,501	3,442	3,391	3,496	3,167	2,936	3,403	4,614	4,033	3,970
Total Operating Expenses	1,338	1,312	1,373	1,438	1,476	1,558	1,658	1,828	1,909	2,137
Depreciation Expense	796	845	896	955	995	1,075	1,146	1,289	1,387	1,590
Other Operating Expenses / (Income)	473	467	477	483	481	483	512	539	522	547
Total Other Income / (Expense), net	-311	-281	-305	-299	-251	-268	-181	-260	-218	-246
Interest Expense	355	382	391	401	381	419	383	486	566	663
Other Income / (Expense), net	44	101	86	102	130	151	202	226	348	417
Income Tax Expense	363	382	576	237	182	155	157	176	183	83
Net Income / (Loss) Attributable to Noncontrolling Interest	6.00	6.00	6.00	6.00	6.00	6.00	5.00	5.00	5.00	5.00
Basic Earnings per Share	$2.60	$2.69	$2.16	$3.34	$3.37	$3.53	$3.86	$4.16	$4.39	$4.43
Weighted Average Basic Shares Outstanding	242.60M	242.60M	242.60M	243.80M	245.60M	247M	256.30M	258.40M	262.80M	266.80M
Diluted Earnings per Share	$2.59	$2.68	$2.14	$3.32	$3.35	$3.50	$3.84	$4.14	$4.38	$4.42
Weighted Average Diluted Shares Outstanding	243.60M	243.40M	244.20M	245.80M	247.10M	248.70M	257.60M	259.50M	263.40M	267.40M
Weighted Average Basic & Diluted Shares Outstanding	244.60M	242.80M	370.21M	372.22M	373.81M	380.93M	385.30M	389.60M	393.87M	397.48M
Cash Dividends to Common per Share	$1.66	$1.72	$1.78	$1.85	$1.92	$2.00	$2.20	$2.36	$2.52	$2.68

This table shows Ameren's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	452	163	264	237	493	158	261	258	456	207
Consolidated Net Income / (Loss)	453	164	265	239	494	159	262	260	457	208
Net Income / (Loss) Continuing Operations	453	164	265	239	494	159	262	260	457	208
Total Pre-Tax Income	531	192	302	277	563	198	306	299	514	151
Total Operating Income	599	276	351	329	614	264	371	361	586	198
Total Gross Profit	1,093	724	798	788	1,130	751	867	868	1,124	794
Total Revenue	2,306	2,046	2,062	1,760	2,060	1,618	1,816	1,693	2,173	1,941
Operating Revenue	2,306	2,046	2,062	1,760	2,060	1,618	1,816	1,693	2,173	1,941
Total Cost of Revenue	1,213	1,322	1,264	972	930	867	949	825	1,049	1,147
Operating Cost of Revenue	1,213	1,322	1,264	972	930	867	949	825	1,049	1,147
Total Operating Expenses	494	448	447	459	516	487	496	507	538	596
Depreciation Expense	350	324	320	335	369	363	361	376	388	465
Other Operating Expenses / (Income)	144	124	127	124	147	124	135	131	150	131
Total Other Income / (Expense), net	-68	-84	-49	-52	-51	-66	-65	-62	-72	-47
Interest Expense	126	130	127	134	152	153	154	165	173	171
Other Income / (Expense), net	58	46	78	82	101	87	89	103	101	124
Income Tax Expense	78	28	37	38	69	39	44	39	57	-57
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	1.00	1.00	2.00	1.00	1.00	1.00	2.00	1.00	1.00
Basic Earnings per Share	$1.75	$0.63	$1.01	$0.90	$1.88	$0.60	$0.98	$0.97	$1.71	$0.77
Weighted Average Basic Shares Outstanding	258.40M	258.40M	262.20M	262.60M	262.80M	262.80M	266.40M	266.70M	266.80M	266.80M
Diluted Earnings per Share	$1.74	$0.63	$1.00	$0.90	$1.87	$0.61	$0.98	$0.97	$1.70	$0.77
Weighted Average Diluted Shares Outstanding	259.50M	259.50M	263.10M	263.20M	263.40M	263.40M	266.80M	266.80M	267.30M	267.40M
Weighted Average Basic & Diluted Shares Outstanding	386.10M	389.60M	390.19M	390.33M	390.52M	393.87M	394.25M	394.39M	394.50M	397.48M

This table details how cash moves in and out of Ameren's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	287	-299	16	39	69	125	-297	61	56	56
Net Cash From Operating Activities	2,031	2,117	2,118	2,170	2,170	1,727	3,252	2,263	2,564	2,763
Net Cash From Continuing Operating Activities	2,035	2,117	2,118	2,170	2,170	1,727	3,252	2,263	2,564	2,763
Net Income / (Loss) Continuing Operations	585	659	529	821	834	877	1,943	1,079	1,157	1,187
Consolidated Net Income / (Loss)	636	659	529	821	834	877	1,943	1,079	1,157	1,187
Depreciation Expense	777	835	876	938	1,002	1,153	2,394	1,373	1,432	1,524
Amortization Expense	119	110	98	115	98	22	158	86	84	100
Non-Cash Adjustments To Reconcile Net Income	53	-6.00	-17	28	-22	11	-16	49	-12	39
Changes in Operating Assets and Liabilities, net	501	519	632	268	258	-336	-1,227	-324	-97	-87
Net Cash From Investing Activities	-1,976	-2,158	-2,204	-2,336	-2,435	-3,329	-6,887	-3,370	-3,798	-4,456
Net Cash From Continuing Investing Activities	-1,951	-2,158	-2,204	-2,336	-2,435	-3,329	-6,887	-3,370	-3,798	-4,456
Purchase of Property, Plant & Equipment	-1,917	-2,076	-2,132	-2,286	-2,411	-3,233	-6,926	-3,351	-3,597	-4,319
Purchase of Investments	-363	-322	-321	-315	-463	-224	-904	-229	-266	-584
Sale and/or Maturity of Investments	349	304	305	299	467	183	878	216	240	564
Other Investing Activities, net	-20	-64	-56	-34	-28	-55	65	-6.00	-175	-117
Net Cash From Financing Activities	232	-258	102	205	334	1,727	3,338	1,168	1,290	1,749
Net Cash From Continuing Financing Activities	232	-258	102	205	334	1,727	3,338	1,168	1,290	1,749
Repayment of Debt	-533	-397	-693	-857	-597	-462	-90	-523	-131	-939
Payment of Dividends	-408	-422	-437	-457	-478	-500	-599	-615	-667	-719
Issuance of Debt	1,197	653	1,271	1,464	1,370	2,233	3,293	1,989	1,762	3,142
Issuance of Common Equity	-	0.00	0.00	74	68	476	308	333	346	273
Other Financing Activities, net	-12	-32	-15	-19	-29	-20	452	-16	-20	-8.00
Cash Interest Paid	335	358	370	387	367	383	779	476	546	611
Cash Income Taxes Paid	-15	-12	-19	21	13	13	-23	-8.00	-24	-92

This table details how cash moves in and out of Ameren's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	7.00	36	21	42	-33	26	109	-80	23	4.00
Net Cash From Operating Activities	-129	664	496	1,695	-160	533	1,084	-35	897	817
Net Cash From Continuing Operating Activities	-129	664	496	1,695	-160	533	1,084	-35	897	817
Net Income / (Loss) Continuing Operations	28	164	265	699	34	159	503	19	457	208
Consolidated Net Income / (Loss)	28	164	265	699	34	159	503	19	457	208
Depreciation Expense	-293	357	350	1,034	-321	369	744	16	382	382
Amortization Expense	-14	23	22	63	-17	16	44	3.00	26	27
Non-Cash Adjustments To Reconcile Net Income	33	-1.00	-7.00	-51	52	-6.00	28	-26	56	-19
Changes in Operating Assets and Liabilities, net	117	121	-134	-50	92	-5.00	-235	-47	-24	219
Net Cash From Investing Activities	611	-912	-964	-2,751	1,059	-1,142	-1,760	-172	-1,174	-1,350
Net Cash From Continuing Investing Activities	611	-912	-964	-2,751	1,059	-1,142	-1,760	-172	-1,174	-1,350
Purchase of Property, Plant & Equipment	606	-914	-931	-2,649	1,009	-1,026	-1,729	-163	-1,137	-1,290
Purchase of Investments	68	-53	-29	-133	6.00	-110	-140	-183	-176	-85
Sale and/or Maturity of Investments	-65	53	17	113	6.00	104	132	177	171	84
Other Investing Activities, net	2.00	2.00	-21	-82	38	-110	-23	-3.00	-32	-59
Net Cash From Financing Activities	-475	284	489	1,098	-932	635	785	127	300	537
Net Cash From Continuing Financing Activities	-479	288	488	1,099	-932	635	785	127	300	537
Repayment of Debt	-450	-73	-3.00	-203	96	-21	-387	37	-514	-75
Payment of Dividends	-154	-150	-167	-169	-164	-167	-180	-179	-180	-180
Issuance of Debt	112	196	678	1,473	-882	493	1,358	268	986	530
Issuance of Common Equity	12	304	5.00	11	12	318	10	11	9.00	243

This table presents Ameren's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	23,640	24,699	25,945	27,215	28,933	32,030	35,735	37,904	40,830	44,598
Total Current Assets	1,917	1,593	1,612	1,533	1,431	1,653	1,968	2,668	2,181	2,264
Cash & Equivalents	292	9.00	10	16	16	139	8.00	10	25	7.00
Accounts Receivable	725	795	838	837	734	749	820	1,100	813	871
Inventories, net	538	527	522	483	494	521	592	667	733	762
Other Current Assets	348	262	242	197	187	244	540	651	504	528
Plant, Property, & Equipment, net	18,799	20,113	21,466	22,810	24,376	26,807	29,261	31,262	33,776	36,304
Total Noncurrent Assets	2,924	2,993	2,867	2,872	3,126	3,159	4,506	3,974	4,873	6,030
Goodwill	411	411	411	411	411	-	411	411	411	411
Employee Benefit Assets	-	-	-	-	-	288	756	411	581	757
Other Noncurrent Operating Assets	2,513	2,582	2,456	2,461	2,715	2,871	3,339	3,152	3,881	4,862
Total Liabilities & Shareholders' Equity	23,640	24,699	25,945	27,215	28,933	32,030	35,735	37,904	40,830	44,598
Total Liabilities	16,552	17,454	18,619	19,442	20,732	22,889	25,906	27,267	29,352	32,355
Total Current Liabilities	2,093	2,674	2,940	2,687	2,505	2,180	2,826	3,366	3,345	3,413
Short-Term Debt	696	1,239	1,325	1,177	882	498	1,050	1,410	1,385	1,460
Accounts Payable	777	805	902	817	874	958	1,095	1,159	1,136	1,059
Customer Deposits	100	107	108	0.00	0.00	-	-	115	176	223
Other Current Liabilities	359	384	454	693	655	549	681	682	501	475
Other Current Nonoperating Liabilities	118	93	99	-	94	114	-	-	147	196
Total Noncurrent Liabilities	14,459	14,780	15,679	16,755	18,227	20,770	23,080	23,901	26,007	28,942
Long-Term Debt	6,880	6,595	7,094	7,859	8,915	11,078	12,562	13,685	15,121	17,262
Asset Retirement Reserve & Litigation Obligation	2,523	2,620	5,025	5,264	5,525	5,978	6,605	6,072	6,284	6,719
Noncurrent Deferred & Payable Income Tax Liabilities	3,945	4,319	2,555	2,666	2,919	3,211	3,499	3,804	4,176	4,474
Other Noncurrent Operating Liabilities	531	477	460	408	467	503	414	340	426	487
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	7,088	7,245	7,326	7,773	8,201	8,938	9,829	10,637	11,478	12,243
Total Preferred & Common Equity	6,946	7,103	7,184	7,631	8,059	8,938	9,700	10,508	11,349	12,114
Total Common Equity	6,946	7,103	7,184	7,631	8,059	8,939	9,700	10,508	11,349	12,114
Common Stock	5,618	5,558	5,542	5,629	5,696	6,182	6,505	6,863	7,219	7,516
Retained Earnings	1,331	1,568	1,660	2,024	2,380	2,757	3,182	3,646	4,136	4,604
Accumulated Other Comprehensive Income / (Loss)	-3.00	-23	-18	-22	-17	-	13	-1.00	-6.00	-6.00
Noncontrolling Interest	-	-	142	142	142	-	129	129	129	129

This table presents Ameren's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	37,657	37,904	38,064	38,947	39,599	40,830	41,306	42,334	43,298	44,598
Total Current Assets	2,518	2,668	2,062	2,019	2,084	2,181	2,084	2,217	2,257	2,264
Cash & Equivalents	7.00	10	10	7.00	8.00	25	85	19	17	7.00
Accounts Receivable	1,093	1,100	986	923	1,022	813	861	983	1,069	871
Inventories, net	695	667	630	711	760	733	679	740	792	762
Other Current Assets	723	651	436	378	294	504	459	475	379	528
Plant, Property, & Equipment, net	30,608	31,262	31,735	32,351	32,938	33,776	34,114	34,873	35,720	36,304
Total Noncurrent Assets	4,531	3,974	4,267	4,577	4,577	4,873	5,108	5,244	5,321	6,030
Goodwill	411	411	411	411	411	411	411	411	411	411
Employee Benefit Assets	813	411	423	442	470	581	597	566	581	757
Other Noncurrent Operating Assets	3,307	3,152	3,433	3,724	3,696	3,881	4,100	4,267	4,329	4,862
Total Liabilities & Shareholders' Equity	37,657	37,904	38,064	38,947	39,599	40,830	41,306	42,334	43,298	44,598
Total Liabilities	27,327	27,267	27,328	28,121	28,427	29,352	29,734	30,666	31,336	32,355
Total Current Liabilities	3,175	3,366	2,757	3,243	4,017	3,345	3,505	3,293	3,567	3,413
Short-Term Debt	1,376	1,410	1,348	1,679	2,189	1,385	2,017	1,490	1,839	1,460
Accounts Payable	820	1,159	664	719	955	1,136	647	774	717	1,059
Customer Deposits	-	115	-	-	-	176	190	197	205	223
Other Current Liabilities	763	682	745	845	664	501	651	655	600	475
Other Current Nonoperating Liabilities	-	-	-	-	-	147	-	177	-	196
Total Noncurrent Liabilities	24,152	23,901	24,571	24,878	24,410	26,007	26,229	27,373	27,769	28,942
Long-Term Debt	13,577	13,685	14,181	14,328	13,829	15,121	15,167	16,280	16,422	17,262
Asset Retirement Reserve & Litigation Obligation	6,429	6,072	6,164	6,220	6,097	6,284	6,372	6,322	6,360	6,719
Noncurrent Deferred & Payable Income Tax Liabilities	3,785	3,804	3,856	3,913	4,068	4,176	4,251	4,325	4,477	4,474
Other Noncurrent Operating Liabilities	361	340	370	417	416	426	439	446	510	487
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	10,330	10,637	10,736	10,826	11,172	11,478	11,572	11,668	11,962	12,243
Total Preferred & Common Equity	10,201	10,508	10,607	10,697	11,043	11,349	11,443	11,539	11,833	12,114
Total Common Equity	10,201	10,508	10,607	10,697	11,043	11,349	11,443	11,539	11,833	12,114
Common Stock	6,551	6,863	6,864	6,883	6,903	7,219	7,231	7,249	7,267	7,516
Retained Earnings	3,636	3,646	3,745	3,817	4,144	4,136	4,219	4,299	4,576	4,604
Accumulated Other Comprehensive Income / (Loss)	14	-1.00	-2.00	-3.00	-4.00	-6.00	-7.00	-9.00	-10	-6.00
Noncontrolling Interest	129	129	129	129	129	129	129	129	129	129

This table displays calculated financial ratios and metrics derived from Ameren's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.74%	-0.36%	1.61%	1.90%	-6.06%	-1.96%	10.36%	24.44%	-5.74%	1.64%
EBITDA Growth	3.53%	7.69%	4.31%	1.70%	-0.60%	5.17%	55.64%	-21.70%	6.94%	3.95%
EBIT Growth	-0.61%	9.21%	5.13%	-2.47%	-4.25%	3.87%	5.79%	13.42%	9.48%	1.42%
NOPAT Growth	1.34%	7.72%	-19.34%	56.00%	-1.23%	6.22%	4.22%	13.13%	3.28%	5.33%
Net Income Growth	7.43%	3.62%	-19.73%	55.20%	1.58%	5.16%	13.46%	8.44%	7.23%	2.59%
EPS Growth	7.92%	3.47%	-20.15%	55.14%	0.90%	4.48%	9.71%	7.81%	5.80%	0.91%
Operating Cash Flow Growth	29.78%	4.23%	0.05%	2.46%	0.00%	-20.41%	88.30%	-30.41%	13.30%	7.76%
Free Cash Flow Firm Growth	323.46%	-13.32%	-97.32%	2,242.59%	-358.41%	-352.85%	-81.11%	62.14%	-55.44%	-39.93%
Invested Capital Growth	4.35%	4.75%	4.43%	6.06%	7.64%	12.20%	15.50%	8.78%	9.88%	10.92%
Revenue Q/Q Growth	-1.01%	0.80%	0.70%	0.32%	-1.71%	0.21%	3.51%	6.72%	-5.40%	4.42%
EBITDA Q/Q Growth	1.66%	0.64%	3.22%	56.02%	69.98%	-23.71%	112.53%	-26.28%	-28.72%	-29.23%
EBIT Q/Q Growth	0.77%	0.14%	5.87%	-3.51%	1.90%	2.47%	0.20%	4.44%	1.55%	-1.48%
NOPAT Q/Q Growth	-0.87%	-3.45%	-13.40%	20.65%	0.80%	3.21%	-1.60%	6.13%	-1.63%	3.65%
Net Income Q/Q Growth	-2.90%	0.46%	-14.81%	18.47%	3.22%	2.45%	1.02%	3.65%	-0.43%	4.31%
EPS Q/Q Growth	0.00%	0.00%	-14.74%	19.00%	3.08%	2.34%	0.52%	3.76%	-0.45%	3.76%
Operating Cash Flow Q/Q Growth	6.67%	3.37%	-3.95%	92.89%	-31.85%	-43.47%	788.52%	-38.15%	-47.38%	-43.82%
Free Cash Flow Firm Q/Q Growth	35.41%	6.48%	-97.04%	221.76%	-5,691.00%	-71.76%	15.85%	30.44%	-117.81%	0.96%
Invested Capital Q/Q Growth	0.81%	0.52%	0.67%	0.68%	2.04%	4.40%	2.01%	0.82%	3.01%	2.82%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.59%	43.35%	45.08%	44.43%	46.41%	49.33%	46.78%	42.01%	46.23%	47.92%
EBITDA Margin	36.06%	38.97%	40.01%	39.93%	42.25%	45.32%	63.92%	40.22%	45.63%	46.66%
Operating Margin	20.65%	21.76%	22.84%	21.57%	21.44%	22.44%	20.85%	19.04%	20.77%	19.89%
EBIT Margin	21.37%	23.42%	24.23%	23.19%	23.64%	25.04%	24.01%	21.88%	25.41%	25.36%
Profit (Net Income) Margin	10.43%	10.85%	8.57%	13.05%	14.11%	15.14%	15.56%	13.56%	15.43%	15.57%
Tax Burden Percent	67.09%	63.30%	47.87%	77.60%	82.09%	84.98%	86.37%	85.98%	86.34%	93.46%
Interest Burden Percent	72.76%	73.16%	73.86%	72.52%	72.73%	71.12%	75.05%	72.09%	70.30%	65.70%
Effective Tax Rate	38.29%	36.70%	52.13%	22.40%	17.91%	15.02%	13.63%	14.02%	13.66%	6.54%
Return on Invested Capital (ROIC)	5.48%	5.65%	4.36%	6.45%	5.97%	5.76%	5.27%	5.33%	5.03%	4.80%
ROIC Less NNEP Spread (ROIC-NNEP)	3.52%	3.32%	2.58%	3.81%	3.78%	3.61%	4.01%	3.75%	3.83%	3.50%
Return on Net Nonoperating Assets (RNNOA)	3.64%	3.55%	2.91%	4.42%	4.48%	4.47%	5.34%	5.22%	5.43%	5.21%
Return on Equity (ROE)	9.12%	9.20%	7.26%	10.87%	10.44%	10.23%	10.60%	10.54%	10.46%	10.01%
Cash Return on Invested Capital (CROIC)	1.22%	1.01%	0.03%	0.58%	-1.39%	-5.74%	-9.12%	-3.09%	-4.39%	-5.56%
Operating Return on Assets (OROA)	5.67%	5.89%	5.91%	5.49%	4.98%	4.76%	4.53%	4.73%	4.84%	4.53%
Return on Assets (ROA)	2.77%	2.73%	2.09%	3.09%	2.97%	2.88%	2.94%	2.93%	2.94%	2.78%
Return on Common Equity (ROCE)	8.94%	9.01%	7.12%	10.67%	10.26%	10.15%	10.53%	10.41%	10.34%	9.90%
Return on Equity Simple (ROE_SIMPLE)	9.16%	9.28%	7.36%	10.76%	10.35%	9.81%	10.26%	10.27%	10.19%	9.80%
Net Operating Profit after Tax (NOPAT)	777	837	675	1,053	1,040	1,105	1,151	1,303	1,345	1,417
NOPAT Margin	12.74%	13.77%	10.93%	16.74%	17.60%	19.07%	18.01%	16.37%	17.94%	18.59%
Net Nonoperating Expense Percent (NNEP)	1.96%	2.32%	1.78%	2.65%	2.18%	2.15%	1.25%	1.57%	1.20%	1.30%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	5.06%	4.81%	4.58%
Cost of Revenue to Revenue	57.41%	56.65%	54.92%	55.57%	53.59%	50.67%	53.22%	57.99%	53.77%	52.08%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.94%	21.59%	22.24%	22.86%	24.97%	26.89%	25.93%	22.97%	25.45%	28.03%
Earnings before Interest and Taxes (EBIT)	1,303	1,423	1,496	1,459	1,397	1,451	1,535	1,741	1,906	1,933
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,199	2,368	2,470	2,512	2,497	2,626	4,087	3,200	3,422	3,557
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.80	2.21	2.53	2.73	3.13	2.95	3.28	3.06	2.41	2.90
Price to Tangible Book Value (P/TBV)	1.91	2.34	2.68	2.88	3.30	2.95	3.42	3.19	2.50	3.00
Price to Revenue (P/Rev)	2.04	2.58	2.94	3.31	4.27	4.56	4.97	4.04	3.64	4.61
Price to Earnings (P/E)	19.79	24.00	34.74	25.52	30.49	30.32	32.10	29.95	23.71	29.75
Dividend Yield	4.91%	4.05%	3.62%	3.30%	2.84%	2.84%	2.67%	2.83%	3.60%	3.01%
Earnings Yield	5.05%	4.17%	2.88%	3.92%	3.28%	3.30%	3.12%	3.34%	4.22%	3.36%
Enterprise Value to Invested Capital (EV/IC)	1.36	1.55	1.69	1.78	1.95	1.87	1.94	1.86	1.57	1.74
Enterprise Value to Revenue (EV/Rev)	3.24	3.87	4.33	4.76	5.95	6.53	7.12	5.95	5.86	7.09
Enterprise Value to EBITDA (EV/EBITDA)	8.98	9.92	10.82	11.93	14.09	14.41	11.14	14.81	12.83	15.18
Enterprise Value to EBIT (EV/EBIT)	15.16	16.51	17.86	20.54	25.18	26.08	29.65	27.22	23.04	27.94
Enterprise Value to NOPAT (EV/NOPAT)	25.43	28.08	39.58	28.46	33.82	34.26	39.53	36.38	32.65	38.12
Enterprise Value to Operating Cash Flow (EV/OCF)	9.73	11.10	12.62	13.81	16.21	21.91	14.00	20.94	17.13	19.55
Enterprise Value to Free Cash Flow (EV/FCFF)	114.24	156.76	6,657.06	318.69	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.07	1.08	1.15	1.16	1.19	1.30	1.38	1.42	1.44	1.53
Long-Term Debt to Equity	0.97	0.91	0.97	1.01	1.09	1.24	1.28	1.29	1.32	1.41
Financial Leverage	1.03	1.07	1.13	1.16	1.18	1.24	1.33	1.39	1.42	1.49
Leverage Ratio	3.29	3.37	3.48	3.52	3.52	3.56	3.61	3.60	3.56	3.60
Compound Leverage Factor	2.40	2.47	2.57	2.55	2.56	2.53	2.71	2.59	2.50	2.37
Debt to Total Capital	51.66%	51.95%	53.47%	53.76%	54.43%	56.43%	58.07%	58.66%	58.98%	60.46%
Short-Term Debt to Total Capital	4.75%	8.22%	8.42%	7.00%	4.90%	2.43%	4.48%	5.48%	4.95%	4.72%
Long-Term Debt to Total Capital	46.92%	43.74%	45.06%	46.75%	49.53%	54.00%	53.59%	53.18%	54.03%	55.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.90%	0.84%	0.79%	0.00%	0.55%	0.50%	0.46%	0.42%
Common Equity to Total Capital	47.37%	47.11%	45.63%	45.40%	44.78%	43.58%	41.38%	40.84%	40.56%	39.12%
Debt to EBITDA	3.45	3.31	3.41	3.60	3.92	4.41	3.33	4.72	4.82	5.26
Net Debt to EBITDA	3.31	3.30	3.40	3.59	3.92	4.36	3.33	4.71	4.82	5.26
Long-Term Debt to EBITDA	3.13	2.79	2.87	3.13	3.57	4.22	3.07	4.28	4.42	4.85
Debt to NOPAT	9.75	9.36	12.47	8.58	9.42	10.48	11.82	11.59	12.27	13.21
Net Debt to NOPAT	9.38	9.35	12.46	8.57	9.40	10.35	11.82	11.58	12.25	13.21
Long-Term Debt to NOPAT	8.86	7.88	10.51	7.46	8.57	10.03	10.91	10.51	11.24	12.18
Altman Z-Score	0.96	1.01	1.04	1.10	1.17	1.12	1.15	1.18	1.00	1.08
Noncontrolling Interest Sharing Ratio	2.04%	1.98%	1.95%	1.88%	1.78%	0.82%	0.68%	1.26%	1.17%	1.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.92	0.60	0.55	0.57	0.57	0.76	0.70	0.79	0.65	0.66
Quick Ratio	0.49	0.30	0.29	0.32	0.30	0.41	0.29	0.33	0.25	0.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	173	150	4.01	94	-243	-1,100	-1,993	-754	-1,173	-1,641
Operating Cash Flow to CapEx	105.95%	101.98%	99.34%	94.93%	90.00%	53.42%	46.95%	67.53%	71.28%	63.97%
Free Cash Flow to Firm to Interest Expense	0.49	0.39	0.01	0.23	-0.64	-2.63	-5.20	-1.55	-2.07	-2.48
Operating Cash Flow to Interest Expense	5.72	5.54	5.42	5.41	5.70	4.12	8.49	4.66	4.53	4.17
Operating Cash Flow Less CapEx to Interest Expense	0.32	0.11	-0.04	-0.29	-0.63	-3.59	-9.59	-2.24	-1.83	-2.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.27	0.25	0.24	0.24	0.21	0.19	0.19	0.22	0.19	0.18
Accounts Receivable Turnover	8.16	7.99	7.56	7.51	7.52	7.81	8.15	8.29	7.84	9.05
Inventory Turnover	6.59	6.46	6.47	6.96	6.48	5.79	6.12	7.33	5.76	5.31
Fixed Asset Turnover	0.34	0.31	0.30	0.28	0.25	0.23	0.23	0.26	0.23	0.22
Accounts Payable Turnover	4.71	4.35	3.97	4.07	3.75	3.21	3.32	4.09	3.51	3.62
Days Sales Outstanding (DSO)	44.71	45.66	48.27	48.59	48.51	46.71	44.78	44.04	46.55	40.32
Days Inventory Outstanding (DIO)	55.36	56.47	56.46	52.46	56.30	63.09	59.69	49.80	63.35	68.72
Days Payable Outstanding (DPO)	77.57	83.88	91.87	89.74	97.44	113.88	110.10	89.15	103.85	100.90
Cash Conversion Cycle (CCC)	22.51	18.24	12.86	11.32	7.37	-4.07	-5.63	4.68	6.05	8.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	14,476	15,163	15,834	16,793	18,076	20,281	23,425	25,482	28,000	31,058
Invested Capital Turnover	0.43	0.41	0.40	0.39	0.34	0.30	0.29	0.33	0.28	0.26
Increase / (Decrease) in Invested Capital	604	687	671	959	1,283	2,205	3,144	2,057	2,518	3,058
Enterprise Value (EV)	19,754	23,497	26,719	29,964	35,172	37,844	45,512	47,383	43,920	54,010
Market Capitalization	12,470	15,672	18,168	20,802	25,249	26,407	31,779	32,169	27,310	35,166
Book Value per Share	$18.76	$19.19	$19.41	$20.52	$21.57	$23.85	$25.18	$27.22	$29.06	$30.71
Tangible Book Value per Share	$17.65	$18.08	$18.30	$19.42	$20.47	$23.85	$24.12	$26.15	$28.01	$29.67
Total Capital	14,664	15,079	15,745	16,809	17,998	20,514	23,441	25,732	27,984	30,965
Total Debt	7,576	7,834	8,419	9,036	9,797	11,576	13,612	15,095	16,506	18,722
Total Long-Term Debt	6,880	6,595	7,094	7,859	8,915	11,078	12,562	13,685	15,121	17,262
Net Debt	7,284	7,825	8,409	9,020	9,781	11,437	13,604	15,085	16,481	18,715
Capital Expenditures (CapEx)	1,917	2,076	2,132	2,286	2,411	3,233	6,926	3,351	3,597	4,319
Debt-free, Cash-free Net Working Capital (DFCFNWC)	228	149	-13	7.00	-208	-168	184	702	196	304
Debt-free Net Working Capital (DFNWC)	520	158	-3.00	23	-192	-29	192	712	221	311
Net Working Capital (NWC)	-176	-1,081	-1,328	-1,154	-1,074	-527	-858	-698	-1,164	-1,149
Net Nonoperating Expense (NNE)	141	178	146	232	206	228	156	224	188	230
Net Nonoperating Obligations (NNO)	7,388	7,918	8,508	9,020	9,875	11,343	13,596	14,845	16,522	18,815
Total Depreciation and Amortization (D&A)	896	945	974	1,053	1,100	1,175	2,552	1,459	1,516	1,624
Debt-free, Cash-free Net Working Capital to Revenue	3.74%	2.45%	-0.21%	0.11%	-3.52%	-2.90%	2.88%	8.82%	2.61%	3.99%
Debt-free Net Working Capital to Revenue	8.53%	2.60%	-0.05%	0.37%	-3.25%	-0.50%	3.00%	8.95%	2.95%	4.08%
Net Working Capital to Revenue	-2.89%	-17.79%	-21.51%	-18.34%	-18.17%	-9.10%	-13.42%	-8.77%	-15.52%	-15.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.60	$2.69	$2.16	$3.34	$3.37	$3.53	$3.86	$4.16	$4.39	$4.43
Adjusted Weighted Average Basic Shares Outstanding	242.60M	242.60M	242.60M	243.80M	245.60M	247M	256.30M	258.40M	262.80M	266.80M
Adjusted Diluted Earnings per Share	$2.59	$2.68	$2.14	$3.32	$3.35	$3.50	$3.84	$4.14	$4.38	$4.42
Adjusted Weighted Average Diluted Shares Outstanding	243.60M	243.40M	244.20M	245.80M	247.10M	248.70M	257.60M	259.50M	263.40M	267.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	370.21M	370.21M	370.21M	372.22M	373.81M	380.93M	385.30M	389.60M	393.87M	397.48M
Normalized Net Operating Profit after Tax (NOPAT)	819	837	987	1,053	1,040	1,105	1,151	1,303	1,345	1,417
Normalized NOPAT Margin	13.44%	13.77%	15.99%	16.74%	17.60%	19.07%	18.01%	16.37%	17.94%	18.59%
Pre Tax Income Margin	15.55%	17.13%	17.90%	16.82%	17.19%	17.81%	18.02%	15.77%	17.87%	16.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.67	3.73	3.83	3.64	3.67	3.46	4.01	3.58	3.37	2.92
NOPAT to Interest Expense	2.19	2.19	1.73	2.63	2.73	2.64	3.01	2.68	2.38	2.14
EBIT Less CapEx to Interest Expense	-1.73	-1.71	-1.63	-2.06	-2.66	-4.25	-14.08	-3.31	-2.99	-3.60
NOPAT Less CapEx to Interest Expense	-3.21	-3.24	-3.73	-3.07	-3.60	-5.08	-15.08	-4.21	-3.98	-4.38
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	64.15%	64.04%	82.61%	55.66%	57.31%	57.01%	60.20%	57.00%	57.65%	60.57%
Augmented Payout Ratio	66.04%	73.14%	87.15%	55.66%	57.31%	57.01%	61.51%	57.00%	57.65%	60.57%

This table displays calculated financial ratios and metrics derived from Ameren's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	27.33%	32.43%	9.74%	1.97%	-10.67%	-20.92%	-11.93%	-3.81%	5.49%	19.96%
EBITDA Growth	-61.96%	-61.91%	8.10%	7.18%	7.71%	4.84%	55.81%	-67.97%	190.45%	-0.68%
EBIT Growth	11.36%	29.84%	9.72%	10.78%	8.83%	9.01%	7.23%	12.90%	-3.92%	-8.26%
NOPAT Growth	11.42%	47.21%	5.56%	7.69%	5.43%	-10.07%	3.14%	10.58%	-3.29%	28.65%
Net Income Growth	6.34%	30.16%	4.74%	14.35%	9.05%	-3.05%	-1.13%	8.79%	-7.49%	30.82%
EPS Growth	5.45%	31.25%	3.09%	12.50%	7.47%	-3.17%	-2.00%	7.78%	-9.09%	26.23%
Operating Cash Flow Growth	-117.06%	-67.77%	27.84%	26.49%	-24.03%	-19.73%	118.55%	-102.06%	660.63%	53.28%
Free Cash Flow Firm Growth	41.51%	38.96%	14.36%	5.31%	24.08%	-26.62%	-13.42%	-27.32%	-83.07%	-20.78%
Invested Capital Growth	10.07%	8.78%	8.96%	8.99%	7.54%	9.88%	9.20%	10.33%	11.13%	10.92%
Revenue Q/Q Growth	33.60%	-11.27%	0.78%	-14.65%	17.05%	-21.46%	12.24%	-6.77%	28.35%	-10.68%
EBITDA Q/Q Growth	-75.12%	100.57%	-62.13%	88.26%	-75.00%	95.23%	-43.27%	-61.30%	126.71%	-33.24%
EBIT Q/Q Growth	77.09%	-50.99%	33.23%	-4.20%	73.97%	-50.91%	31.05%	0.87%	48.06%	-53.13%
NOPAT Q/Q Growth	93.86%	-53.87%	30.65%	-7.83%	89.79%	-60.65%	49.84%	-1.18%	65.97%	-47.65%
Net Income Q/Q Growth	116.75%	-63.80%	61.59%	-9.81%	106.69%	-67.81%	64.78%	-0.76%	75.77%	-54.49%
EPS Q/Q Growth	117.50%	-63.79%	58.73%	-10.00%	107.78%	-67.38%	60.66%	-1.02%	75.26%	-54.71%
Operating Cash Flow Q/Q Growth	-109.63%	614.73%	-82.55%	241.73%	-109.44%	433.13%	-63.53%	-103.23%	2,662.86%	-8.92%
Free Cash Flow Firm Q/Q Growth	11.60%	-1.13%	-1.58%	-4.28%	29.13%	-68.66%	13.00%	-17.05%	-1.91%	-11.28%
Invested Capital Q/Q Growth	2.69%	0.82%	3.03%	2.17%	1.33%	3.01%	2.01%	3.23%	2.06%	2.82%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.40%	35.39%	38.70%	44.77%	54.85%	46.42%	47.74%	51.27%	51.73%	40.91%
EBITDA Margin	15.18%	34.31%	38.85%	85.68%	18.30%	45.49%	68.72%	28.53%	50.39%	37.66%
Operating Margin	25.98%	13.49%	17.02%	18.69%	29.81%	16.32%	20.43%	21.32%	26.97%	10.20%
EBIT Margin	28.49%	15.74%	20.81%	23.35%	34.71%	21.69%	25.33%	27.41%	31.62%	16.59%
Profit (Net Income) Margin	19.64%	8.02%	12.85%	13.58%	23.98%	9.83%	14.43%	15.36%	21.03%	10.72%
Tax Burden Percent	85.31%	85.42%	87.75%	86.28%	87.74%	80.30%	85.62%	86.96%	88.91%	137.75%
Interest Burden Percent	80.82%	59.63%	70.40%	67.40%	78.74%	56.41%	66.52%	64.44%	74.82%	46.89%
Effective Tax Rate	14.69%	14.58%	12.25%	13.72%	12.26%	19.70%	14.38%	13.04%	11.09%	-37.75%
Return on Invested Capital (ROIC)	6.85%	3.75%	4.83%	5.13%	7.91%	3.67%	4.62%	4.72%	6.10%	3.63%
ROIC Less NNEP Spread (ROIC-NNEP)	6.44%	3.24%	4.54%	4.83%	7.62%	3.34%	4.28%	4.41%	5.73%	3.26%
Return on Net Nonoperating Assets (RNNOA)	8.98%	4.51%	6.52%	7.10%	10.96%	4.73%	6.26%	6.65%	8.48%	4.86%
Return on Equity (ROE)	15.83%	8.26%	11.35%	12.22%	18.87%	8.41%	10.88%	11.37%	14.58%	8.49%
Cash Return on Invested Capital (CROIC)	-4.50%	-3.09%	-3.33%	-3.40%	-2.05%	-4.39%	-3.86%	-4.91%	-5.77%	-5.56%
Operating Return on Assets (OROA)	5.87%	3.40%	4.56%	5.02%	7.12%	4.13%	4.63%	4.85%	5.57%	2.96%
Return on Assets (ROA)	4.05%	1.73%	2.82%	2.92%	4.92%	1.87%	2.64%	2.72%	3.70%	1.91%
Return on Common Equity (ROCE)	15.63%	8.15%	11.21%	12.07%	18.64%	8.31%	10.75%	11.24%	14.42%	8.39%
Return on Equity Simple (ROE_SIMPLE)	10.20%	0.00%	10.29%	10.48%	10.52%	0.00%	10.08%	10.18%	9.62%	0.00%
Net Operating Profit after Tax (NOPAT)	511	236	308	284	539	212	318	314	521	273
NOPAT Margin	22.16%	11.52%	14.94%	16.13%	26.15%	13.10%	17.49%	18.54%	23.98%	14.05%
Net Nonoperating Expense Percent (NNEP)	0.41%	0.50%	0.29%	0.29%	0.29%	0.34%	0.34%	0.32%	0.37%	0.37%
Return On Investment Capital (ROIC_SIMPLE)	-	0.92%	-	-	-	0.76%	-	-	-	0.88%
Cost of Revenue to Revenue	52.60%	64.61%	61.30%	55.23%	45.15%	53.58%	52.26%	48.73%	48.27%	59.09%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.42%	21.90%	21.68%	26.08%	25.05%	30.10%	27.31%	29.95%	24.76%	30.71%
Earnings before Interest and Taxes (EBIT)	657	322	429	411	715	351	460	464	687	322
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	350	702	801	1,508	377	736	1,248	483	1,095	731
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.88	3.06	3.04	2.88	2.56	2.41	2.52	2.43	2.92	2.90
Price to Tangible Book Value (P/TBV)	3.00	3.19	3.16	2.99	2.65	2.50	2.62	2.52	3.02	3.00
Price to Revenue (P/Rev)	3.94	4.04	3.96	3.77	3.56	3.64	3.98	3.90	4.73	4.61
Price to Earnings (P/E)	28.36	29.95	29.71	27.58	24.39	23.71	25.12	23.96	30.44	29.75
Dividend Yield	3.05%	2.83%	2.90%	3.09%	3.43%	3.60%	3.49%	3.66%	3.02%	3.01%
Earnings Yield	3.53%	3.34%	3.37%	3.63%	4.10%	4.22%	3.98%	4.17%	3.28%	3.36%
Enterprise Value to Invested Capital (EV/IC)	1.76	1.86	1.83	1.75	1.63	1.57	1.61	1.55	1.75	1.74
Enterprise Value to Revenue (EV/Rev)	5.96	5.95	5.89	5.74	5.59	5.86	6.35	6.39	7.24	7.09
Enterprise Value to EBITDA (EV/EBITDA)	10.24	14.81	10.25	9.83	9.24	12.83	8.64	10.66	10.52	15.18
Enterprise Value to EBIT (EV/EBIT)	26.67	27.22	26.93	25.79	23.63	23.04	23.79	23.07	26.95	27.94
Enterprise Value to NOPAT (EV/NOPAT)	36.22	36.38	36.34	35.04	32.43	32.65	34.01	33.15	38.67	38.12
Enterprise Value to Operating Cash Flow (EV/OCF)	12.15	20.94	10.53	9.57	9.10	17.13	8.24	11.89	10.75	19.55
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.45	1.42	1.45	1.48	1.43	1.44	1.49	1.52	1.53	1.53
Long-Term Debt to Equity	1.31	1.29	1.32	1.32	1.24	1.32	1.31	1.40	1.37	1.41
Financial Leverage	1.39	1.39	1.44	1.47	1.44	1.42	1.46	1.51	1.48	1.49
Leverage Ratio	3.59	3.60	3.59	3.65	3.59	3.56	3.56	3.61	3.58	3.60
Compound Leverage Factor	2.90	2.15	2.53	2.46	2.83	2.01	2.37	2.33	2.68	1.69
Debt to Total Capital	59.14%	58.66%	59.12%	59.65%	58.91%	58.98%	59.76%	60.36%	60.42%	60.46%
Short-Term Debt to Total Capital	5.44%	5.48%	5.13%	6.26%	8.05%	4.95%	7.01%	5.06%	6.08%	4.72%
Long-Term Debt to Total Capital	53.70%	53.18%	53.99%	53.40%	50.86%	54.03%	52.74%	55.30%	54.34%	55.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.51%	0.50%	0.49%	0.48%	0.47%	0.46%	0.45%	0.44%	0.43%	0.42%
Common Equity to Total Capital	40.35%	40.84%	40.38%	39.87%	40.61%	40.56%	39.79%	39.20%	39.15%	39.12%
Debt to EBITDA	3.44	4.72	3.32	3.35	3.34	4.82	3.22	4.12	3.63	5.26
Net Debt to EBITDA	3.44	4.71	3.32	3.35	3.33	4.82	3.21	4.12	3.63	5.26
Long-Term Debt to EBITDA	3.13	4.28	3.03	3.00	2.88	4.42	2.84	3.78	3.27	4.85
Debt to NOPAT	12.18	11.59	11.78	11.96	11.71	12.27	12.68	12.83	13.36	13.21
Net Debt to NOPAT	12.18	11.58	11.77	11.95	11.71	12.25	12.62	12.82	13.35	13.21
Long-Term Debt to NOPAT	11.06	10.51	10.75	10.70	10.11	11.24	11.19	11.76	12.01	12.18
Altman Z-Score	1.01	1.06	1.08	1.00	0.94	0.88	0.90	0.87	0.99	0.96
Noncontrolling Interest Sharing Ratio	1.28%	1.26%	1.25%	1.24%	1.20%	1.17%	1.16%	1.15%	1.12%	1.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.79	0.79	0.75	0.62	0.52	0.65	0.59	0.67	0.63	0.66
Quick Ratio	0.35	0.33	0.36	0.29	0.26	0.25	0.27	0.30	0.30	0.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,801	-1,821	-1,850	-1,929	-1,367	-2,306	-2,098	-2,456	-2,503	-2,785
Operating Cash Flow to CapEx	0.00%	72.65%	53.28%	63.99%	0.00%	51.95%	62.70%	-21.47%	78.89%	63.33%
Free Cash Flow to Firm to Interest Expense	-14.29	-14.01	-14.57	-14.40	-9.00	-15.07	-13.63	-14.89	-14.47	-16.29
Operating Cash Flow to Interest Expense	-1.02	5.11	3.91	12.65	-1.05	3.48	7.04	-0.21	5.19	4.78
Operating Cash Flow Less CapEx to Interest Expense	3.79	-1.92	-3.43	-7.12	5.59	-3.22	-4.19	-1.20	-1.39	-2.77
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.21	0.22	0.22	0.21	0.21	0.19	0.18	0.18	0.18	0.18
Accounts Receivable Turnover	7.27	8.29	8.50	8.50	7.50	7.84	7.85	7.54	6.98	9.05
Inventory Turnover	6.56	7.33	8.30	7.28	6.17	5.76	5.68	4.92	4.76	5.31
Fixed Asset Turnover	0.25	0.26	0.27	0.26	0.25	0.23	0.22	0.21	0.21	0.22
Accounts Payable Turnover	5.19	4.09	7.05	5.90	5.06	3.51	5.67	4.78	4.41	3.62
Days Sales Outstanding (DSO)	50.20	44.04	42.96	42.93	48.69	46.55	46.47	48.40	52.28	40.32
Days Inventory Outstanding (DIO)	55.66	49.80	43.99	50.15	59.17	63.35	64.25	74.16	76.76	68.72
Days Payable Outstanding (DPO)	70.37	89.15	51.79	61.82	72.18	103.85	64.35	76.30	82.69	100.90
Cash Conversion Cycle (CCC)	35.49	4.68	35.15	31.27	35.67	6.05	46.37	46.25	46.34	8.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	25,276	25,482	26,255	26,826	27,182	28,000	28,671	29,596	30,206	31,058
Invested Capital Turnover	0.31	0.33	0.32	0.32	0.30	0.28	0.26	0.25	0.25	0.26
Increase / (Decrease) in Invested Capital	2,312	2,057	2,158	2,213	1,906	2,518	2,416	2,770	3,024	3,058
Enterprise Value (EV)	44,453	47,383	47,915	46,911	44,355	43,920	46,085	45,915	52,867	54,010
Market Capitalization	29,378	32,169	32,267	30,782	28,216	27,310	28,857	28,035	34,494	35,166
Book Value per Share	$26.43	$27.22	$27.23	$27.42	$28.29	$29.06	$29.05	$29.27	$30.00	$30.71
Tangible Book Value per Share	$25.37	$26.15	$26.17	$26.36	$27.24	$28.01	$28.01	$28.23	$28.96	$29.67
Total Capital	25,283	25,732	26,265	26,833	27,190	27,984	28,756	29,438	30,223	30,965
Total Debt	14,953	15,095	15,529	16,007	16,018	16,506	17,184	17,770	18,261	18,722
Total Long-Term Debt	13,577	13,685	14,181	14,328	13,829	15,121	15,167	16,280	16,422	17,262
Net Debt	14,946	15,085	15,519	16,000	16,010	16,481	17,099	17,751	18,244	18,715
Capital Expenditures (CapEx)	-606	914	931	2,649	-1,009	1,026	1,729	163	1,137	1,290
Debt-free, Cash-free Net Working Capital (DFCFNWC)	712	702	643	448	248	196	511	395	512	304
Debt-free Net Working Capital (DFNWC)	719	712	653	455	256	221	596	414	529	311
Net Working Capital (NWC)	-657	-698	-695	-1,224	-1,933	-1,164	-1,421	-1,076	-1,310	-1,149
Net Nonoperating Expense (NNE)	58	72	43	45	45	53	56	54	64	65
Net Nonoperating Obligations (NNO)	14,946	14,845	15,519	16,000	16,010	16,522	17,099	17,928	18,244	18,815
Total Depreciation and Amortization (D&A)	-307	380	372	1,097	-338	385	788	19	408	409
Debt-free, Cash-free Net Working Capital to Revenue	9.55%	8.82%	7.90%	5.48%	3.13%	2.61%	7.04%	5.50%	7.01%	3.99%
Debt-free Net Working Capital to Revenue	9.64%	8.95%	8.02%	5.57%	3.23%	2.95%	8.22%	5.76%	7.25%	4.08%
Net Working Capital to Revenue	-8.81%	-8.77%	-8.54%	-14.97%	-24.38%	-15.52%	-19.59%	-14.97%	-17.95%	-15.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.75	$0.63	$1.01	$0.90	$1.88	$0.60	$0.98	$0.97	$1.71	$0.77
Adjusted Weighted Average Basic Shares Outstanding	258.40M	258.40M	262.20M	262.60M	262.80M	262.80M	266.40M	266.70M	266.80M	266.80M
Adjusted Diluted Earnings per Share	$1.74	$0.63	$1.00	$0.90	$1.87	$0.61	$0.98	$0.97	$1.70	$0.77
Adjusted Weighted Average Diluted Shares Outstanding	259.50M	259.50M	263.10M	263.20M	263.40M	263.40M	266.80M	266.80M	267.30M	267.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	386.10M	389.60M	390.19M	390.33M	390.52M	393.87M	394.25M	394.39M	394.50M	397.48M
Normalized Net Operating Profit after Tax (NOPAT)	511	236	308	284	539	212	318	314	521	139
Normalized NOPAT Margin	22.16%	11.52%	14.94%	16.13%	26.15%	13.10%	17.49%	18.54%	23.98%	7.14%
Pre Tax Income Margin	23.03%	9.38%	14.65%	15.74%	27.33%	12.24%	16.85%	17.66%	23.65%	7.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.21	2.48	3.38	3.07	4.70	2.29	2.99	2.81	3.97	1.88
NOPAT to Interest Expense	4.06	1.81	2.43	2.12	3.54	1.39	2.06	1.90	3.01	1.60
EBIT Less CapEx to Interest Expense	10.02	-4.55	-3.95	-16.70	11.34	-4.41	-8.24	1.82	-2.60	-5.66
NOPAT Less CapEx to Interest Expense	8.87	-5.22	-4.91	-17.65	10.18	-5.32	-9.16	0.91	-3.56	-5.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	61.19%	57.00%	62.33%	61.64%	60.33%	57.65%	63.69%	63.40%	66.87%	60.57%
Augmented Payout Ratio	60.81%	57.00%	62.79%	62.18%	60.41%	57.65%	63.95%	63.40%	67.49%	60.57%

Frequently Asked Questions About Ameren's Financials

When does Ameren's fiscal year end?

According to the most recent income statement we have on file, Ameren's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ameren's net income changed over the last 9 years?

Ameren's net income appears to be on an upward trend, with a most recent value of $1.19 billion in 2024, rising from $636 million in 2015. The previous period was $1.16 billion in 2023.

What is Ameren's operating income?

Ameren's total operating income in 2024 was $1.52 billion, based on the following breakdown:

Total Gross Profit: $3.65 billion
Total Operating Expenses: $2.14 billion

How has Ameren revenue changed over the last 9 years?

Over the last 9 years, Ameren's total revenue changed from $6.10 billion in 2015 to $7.62 billion in 2024, a change of 25.0%.

How much debt does Ameren have?

Ameren's total liabilities were at $32.36 billion at the end of 2024, a 10.2% increase from 2023, and a 95.5% increase since 2015.

How much cash does Ameren have?

In the past 9 years, Ameren's cash and equivalents has ranged from $7 million in 2024 to $292 million in 2015, and is currently $7 million as of their latest financial filing in 2024.

How has Ameren's book value per share changed over the last 9 years?

Over the last 9 years, Ameren's book value per share changed from 18.76 in 2015 to 30.71 in 2024, a change of 63.7%.

Remove Ads

Related Companies

This page (NYSE:AEE) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ameren (AEE) Financials

Frequently Asked Questions About Ameren's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ameren (AEE) Financials

Annual Income Statements for Ameren

Quarterly Income Statements for Ameren

Annual Cash Flow Statements for Ameren

Quarterly Cash Flow Statements for Ameren

Annual Balance Sheets for Ameren

Quarterly Balance Sheets for Ameren

Annual Metrics and Ratios for Ameren

Quarterly Metrics and Ratios for Ameren

Frequently Asked Questions About Ameren's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools